{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T06:01:38Z","timestamp":1794031298228,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009559","name":"Life Sciences Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.antiviral.2024.106002","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:58:13Z","timestamp":1726127893000},"page":"106002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The ApoA1-mimetic peptide 4F blocks flavivirus NS1-triggered endothelial dysfunction and protects against lethal dengue virus challenge"],"prefix":"10.1016","volume":"231","author":[{"given":"Pedro H.","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3737-9427","authenticated-orcid":false,"given":"E. Vanessa","family":"Jimenez-Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2403-5868","authenticated-orcid":false,"given":"Eduarda","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo","family":"Mohana-Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1991-629X","authenticated-orcid":false,"given":"Scott B.","family":"Biering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-4037","authenticated-orcid":false,"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2024.106002_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JCM.40.02.376-381.2002","article-title":"Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections","volume":"40","author":"Alcon","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2024.106002_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20092545","article-title":"Antagonism of the complement component C4 by flavivirus nonstructural protein NS1","volume":"207","author":"Avirutnan","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2024.106002_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2024.106002_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153600","article-title":"Dengue virus NS1 protein conveys pro\u2010inflammatory signals by docking onto high\u2010density lipoproteins","volume":"23","author":"Benfrid","year":"2022","journal-title":"EMBO Rep."},{"issue":"6525","key":"10.1016\/j.antiviral.2024.106002_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1126\/science.abc0476","article-title":"Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction","volume":"371","author":"Biering","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2024.106002_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01974-20","article-title":"ApoA1 neutralizes proinflammatory effects of dengue virus NS1 protein and modulates viral immune evasion","volume":"95","author":"Coelho","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2024.106002_bib7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2024.106002_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008509","article-title":"Matrix metalloproteinase 9 facilitates Zika virus invasion of the testis by modulating the integrity of the blood-testis barrier","volume":"16","author":"Hui","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2024.106002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002203","article-title":"Zika virus infection as a cause of congenital brain abnormalities and guillain\u2013barr\u00e9 syndrome: systematic review","volume":"14","author":"Krauer","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2024.106002_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/ija.IJA_751_18","article-title":"Endothelial glycocalyx: role in body fluid homeostasis and fluid management","volume":"63","author":"Kundra","year":"2019","journal-title":"Indian J. Anaesth."},{"key":"10.1016\/j.antiviral.2024.106002_bib11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/343813","article-title":"High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever","volume":"186","author":"Libraty","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2024.106002_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00661-22","article-title":"Molecular determinants of tissue specificity of flavivirus nonstructural protein 1 interaction with endothelial cells","volume":"96","author":"Lo","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2024.106002_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.abb9425","article-title":"A broadly protective antibody that targets the flavivirus NS1 protein","volume":"371","author":"Modhiran","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2024.106002_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2024.106002_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2024.106002_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/hc0302.103711","article-title":"Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol","volume":"105","author":"Navab","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2024.106002_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1194\/jlr.M013144","article-title":"Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally","volume":"52","author":"Navab","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.antiviral.2024.106002_bib18","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1099\/vir.0.045088-0","article-title":"Characterization of a model of lethal dengue virus 2 infection in C57BL\/6 mice deficient in the alpha\/beta interferon receptor","volume":"93","author":"Orozco","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2024.106002_bib19","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1194\/jlr.M800046-JLR200","article-title":"L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice","volume":"49","author":"Peterson","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.antiviral.2024.106002_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007736","article-title":"A novel interaction between dengue virus nonstructural protein 1 and the NS4A-2K-4B precursor is required for viral RNA replication but not for formation of the membranous replication organelle","volume":"15","author":"P\u0142aszczyca","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2024.106002_bib21","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/pathogens11060615","article-title":"Flavivirus NS1 triggers tissue-specific disassembly of intercellular junctions leading to barrier dysfunction and vascular leak in a GSK-3\u03b2-dependent manner","volume":"11","author":"Puerta-Guardo","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.antiviral.2024.106002_bib22","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism","volume":"26","author":"Puerta-Guardo","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2024.106002_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005738","article-title":"Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability","volume":"12","author":"Puerta-Guardo","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2024.106002_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/infdis\/jiz331","article-title":"Zika virus nonstructural protein 1 disrupts glycosaminoglycans and causes permeability in developing human placentas","volume":"221","author":"Puerta-Guardo","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2024.106002_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005277","article-title":"Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins","volume":"11","author":"Scaturro","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2024.106002_bib26","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s10753-014-9864-7","article-title":"L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils","author":"Sharifov","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.antiviral.2024.106002_bib27","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1038\/s41467-022-34415-1","article-title":"CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever","volume":"13","author":"Shu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2024.106002_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105330","article-title":"Sulfated \u03b2-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis","volume":"203","author":"Sousa","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2024.106002_bib29","article-title":"Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1","author":"Sousa","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.antiviral.2024.106002_bib30","first-page":"992","article-title":"Association of endothelial glycocalyx and tight and adherens junctions with severity of plasma leakage in dengue infection","volume":"215","author":"Suwarto","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2024.106002_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007938","article-title":"Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutation","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2024.106002_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02440-21","article-title":"Human monoclonal antibodies against NS1 protein protect against lethal West Nile virus infection","volume":"12","author":"Wessel","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2024.106002_bib33","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.15252\/embj.201695290","article-title":"Contribution of intertwined loop to membrane association revealed by Zika virus full\u2010length NS 1 structure","volume":"35","author":"Xu","year":"2016","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.antiviral.2024.106002_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/life11070615","article-title":"Flavivirus: from structure to therapeutics development","volume":"25","author":"Zhao","year":"2021","journal-title":"Life"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354224002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354224002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T21:52:13Z","timestamp":1780177933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354224002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"alternative-id":["S0166354224002110"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2024.106002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ApoA1-mimetic peptide 4F blocks flavivirus NS1-triggered endothelial dysfunction and protects against lethal dengue virus challenge","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2024.106002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106002"}}